West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
417.83
+0.03 (0.01%)
Nov 17, 2026, 10:31 AM EST - Market open
WST Revenue
West Pharmaceutical Services had revenue of $874.50M in the quarter ending September 30, 2026, with 8.69% growth. This brings the company's total for the last twelve months to $3.40B, up 12.55% year-over-year. In the year 2025, West Pharmaceutical Services had annual revenue of $3.07B with 6.25% growth. That makes West Pharmaceutical Services the 3,502nd largest company in the world by revenue and 987th in the United States.
Revenue (ttm)
$3.40B
Revenue Growth
+12.55%
P/S Ratio
8.57
Revenue / Employee
$314,509
Employees
10,800
Market Cap
29.11B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full WST breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.07B | 180.90M | 6.25% |
| Dec 31, 2024 | 2.89B | -56.60M | -1.92% |
| Dec 31, 2023 | 2.95B | 62.90M | 2.18% |
| Dec 31, 2022 | 2.89B | 55.30M | 1.95% |
| Dec 31, 2021 | 2.83B | 684.70M | 31.89% |
| Dec 31, 2020 | 2.15B | 307.00M | 16.69% |
| Dec 31, 2019 | 1.84B | 122.50M | 7.13% |
| Dec 31, 2018 | 1.72B | 118.30M | 7.40% |
| Dec 31, 2017 | 1.60B | 90.00M | 5.96% |
| Dec 31, 2016 | 1.51B | 109.30M | 7.81% |
| Dec 31, 2015 | 1.40B | -21.60M | -1.52% |
| Dec 31, 2014 | 1.42B | 53.00M | 3.87% |
| Dec 31, 2013 | 1.37B | 102.00M | 8.05% |
| Dec 31, 2012 | 1.27B | 74.10M | 6.21% |
| Dec 31, 2011 | 1.19B | 87.60M | 7.93% |
| Dec 31, 2010 | 1.10B | 49.00M | 4.64% |
| Dec 31, 2009 | 1.06B | 4.60M | 0.44% |
| Dec 31, 2008 | 1.05B | 31.00M | 3.04% |
| Dec 31, 2007 | 1.02B | 106.80M | 11.69% |
| Dec 31, 2006 | 913.30M | 213.60M | 30.53% |
| Dec 31, 2005 | 699.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medline | 30.68B |
| Becton, Dickinson and Company | 19.46B |
| Baxter International | 11.61B |
| Alcon | 10.98B |
| Solventum | 8.16B |
| Avantor | 6.64B |
| ResMed | 5.73B |
| The Cooper Companies | 4.24B |
WST News
- 13 days ago - West to Participate in Upcoming Investor Conference - PRNewsWire
- 18 days ago - West Pharmaceutical price target raised to $500 from $420 at TD Cowen - TheFly
- 18 days ago - West Pharmaceutical price target raised to $480 from $440 at Evercore ISI - TheFly
- 18 days ago - West Pharmaceutical price target raised to $494 from $412 at Citi - TheFly
- 18 days ago - West Pharmaceutical price target raised to $500 from $440 at Barclays - TheFly
- 19 days ago - West Pharmaceutical Services Earnings Call Transcript: Q3 2026 - Transcripts
- 19 days ago - West Pharmaceutical Services Slides: Q3 2026 - Filings
- 19 days ago - West Pharmaceutical Services Earnings release: Q3 2026 - Filings